Am J Trop Med Hyg. 2012 May;86(5):745-752. doi: 10.4269/ajtmh.2012.11-0784.
Dengue, endemic in Puerto Rico, reached a record high in 2010. To inform policy makers, we derived annual economic cost. We assessed direct and indirect costs of hospitalized and ambulatory dengue illness in 2010 dollars through surveillance data and interviews with 100 laboratory-confirmed dengue patients treated in 2008-2010. We corrected for underreporting by using setting-specific expansion factors. Work absenteeism because of a dengue episode exceeded the absenteeism for an episode of influenza or acute otitis media. From 2002 to 2010, the aggregate annual cost of dengue illness averaged $38.7 million, of which 70% was for adults (age 15+ years). Hospitalized patients accounted for 63% of the cost of dengue illness, and fatal cases represented an additional 17%. Households funded 48% of dengue illness cost, the government funded 24%, insurance funded 22%, and employers funded 7%. Including dengue surveillance and vector control activities, the overall annual cost of dengue was $46.45 million ($12.47 per capita).
登革热在波多黎各流行,2010 年达到历史最高水平。为了给决策者提供信息,我们计算了每年的经济成本。我们通过监测数据和对 2008-2010 年期间 100 名经实验室确诊的登革热患者的访谈,评估了 2010 年美元计价的住院和门诊登革热疾病的直接和间接成本。我们使用特定环境的扩展因素来纠正漏报。由于登革热发作而导致的旷工超过了流感或急性中耳炎发作的旷工。从 2002 年到 2010 年,登革热疾病的年均总成本为 3870 万美元,其中 70%为成年人(15 岁以上)。住院患者占登革热疾病费用的 63%,死亡病例占 17%。家庭承担了 48%的登革热疾病费用,政府承担了 24%,保险承担了 22%,雇主承担了 7%。包括登革热监测和病媒控制活动在内,登革热的总年度成本为 4645 万美元(人均 12.47 美元)。